ISSN : 1301-5680
e-ISSN : 2149-8156
Turkish Journal of Thoracic and Cardiovascular Surgery     
The use of rivaroxaban in deep venous thrombosis associated with vena cava inferior agenesis
Ali Ahmet Arıkan1, Selçuk Emre2, Bayraktar Fatih Avni2
1Department of Cardiovascular Surgery, Derince Training and Research Hospital, Kocaeli, Turkey
2Department of Cardiovascular Surgery, Muş State Hospital, Muş, Turkey
DOI : 10.5606/tgkdc.dergisi.2019.17672
Inferior vena cava agenesis is a rare anomaly which may result in deep vein thrombosis. There is no clear scientific evidence for the most effective therapeutic management, optimal duration, or the choice of anticoagulant therapy. Herein, we report an 18-year-old male case with deep vein thrombosis associated with inferior vena cava agenesis who was on rivaroxaban as a lifelong anticoagulation treatment for symptoms of venous stasis and the presence of heterozygotic thrombophilic mutations.
Keywords : Inferior, rivaroxaban, thrombophilia, vascular malformation, vein thrombosis, vena cava
Viewed : 3462
Downloaded : 949